Picture of Syncom Formulations (India) logo

SYNCOMF Syncom Formulations (India) Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual cashflow statement for Syncom Formulations (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

C2020
March 31st
R2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line173407262266340
Depreciation
Non-Cash Items-51.1-61.3-111-107-82.1
Unusual Items
Other Non-Cash Items
Changes in Working Capital-104-406-26.6-99.2-365
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities58.6-20.6163105-59.6
Capital Expenditures-17.5-26.6-113-206-81.4
Purchase of Fixed Assets
Other Investing Cash Flow Items32.6-727-158-243912
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities15.1-754-271-450830
Financing Cash Flow Items0.113-0.881-10.4-21.5-38.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-65.272082.9350-146
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash8.59-54.6-24.55.78625